ProteoWise, Inc.
New Haven, US · Founded 2018 · Delaware corporation · 2 known investors
ProteoWise develops the Hyperblot instrument, which enables high-throughput multiplex protein analysis for life science researchers. The benchtop proteomics platform simplifies sample-to-data workflows for academic and research laboratories.
BiotechDeep TechMedical Devices
Founders & leadership
EG
Erik GuntherExecutive Officer, Director
DW
Daniel WagnerDirector
BD
Benjamin D. CombDirector
DS
David SmollerDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$2.3MraisedDec 2024 · 6 investors · BiotechnologyRule 506(b)
▶$2.3MraisedDec 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel WagnerDirector
- Benjamin D. CombDirector
- Erik GuntherExecutive Officer, Director
- David SmollerDirector
- Offering amount
- $10M
- Amount sold
- $2.3M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedApr 2021 · 5 investors · BiotechnologyRule 506(b)
▶$2.7MraisedApr 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Erik GuntherExecutive Officer, Director, Promoter
- Benjamin CombDirector
- Daniel WagnerDirector
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6.3MraisedMar 2020 · 15 investors · BiotechnologyRule 506(b)
▶$6.3MraisedMar 2020 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin CombDirector
- Erik GuntherExecutive Officer, Director, Promoter
- Daniel WagnerDirector
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- Finders' fees
- $89.7K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- ProteoWise, Inc. - Connecticut Innovations Connecticut Innovationsctinnovations.com · 2020